3 No-Brainer Dividend Stocks to Buy in March
Some decisions are painstakingly difficult. Others are downright easy. Choosing from the thousands of dividend stocks on the market can fall into the former category. But it doesn't have to.
Three Fool.com contributors selected dividend stocks they believe are no-brainer picks to buy in March. Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).
Keith Speights (AbbVie): I don't think anyone would seriously challenge AbbVie's credentials as a solid dividend stock. After all, the company is a Dividend King with 51 consecutive years of dividend increases. Its dividend has grown by a whopping 270% since the spinoff from Abbott Labs in 2013. AbbVie's dividend yield stands at nearly 4%.
Source Fool.com
